Clinical Trial

Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this research study is to develop and pilot a multiple health behavior change intervention for weight loss and smoking cessation using medication (Naltrexone + Bupropion) and behavior therapy in adults seeking bariatric surgery.
Protocol Amendment History 2 changes
critical Trial status changed: Recruiting → Not Yet Recruiting 2026-07-09
notable Sponsor changed: Yale University -> Medical University of South Carolina 2026-07-09
Trial Details
NCT Number NCT07224087
Lead Sponsor Medical University of South Carolina
Collaborators: American Society for Metabolic and Bariatric Surgery
Conditions Obesity, Smoking Cessation, Bariatric Surgery Patients
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-08